| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.079 | 0.2 |